| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | eosinophil fate commitment | 3.67e-06 | 2 | 40 | 2 | GO:0035854 | |
| GeneOntologyBiologicalProcess | regulation of primitive erythrocyte differentiation | 1.10e-05 | 3 | 40 | 2 | GO:0010725 | |
| GeneOntologyBiologicalProcess | pro-T cell differentiation | 2.19e-05 | 4 | 40 | 2 | GO:0002572 | |
| GeneOntologyBiologicalProcess | eosinophil differentiation | 7.65e-05 | 7 | 40 | 2 | GO:0030222 | |
| GeneOntologyBiologicalProcess | mammary gland duct morphogenesis | 9.06e-05 | 45 | 40 | 3 | GO:0060603 | |
| GeneOntologyBiologicalProcess | primitive erythrocyte differentiation | 1.02e-04 | 8 | 40 | 2 | GO:0060319 | |
| GeneOntologyBiologicalProcess | positive regulation of mammary gland epithelial cell proliferation | 1.31e-04 | 9 | 40 | 2 | GO:0033601 | |
| GeneOntologyBiologicalProcess | mammary duct terminal end bud growth | 1.31e-04 | 9 | 40 | 2 | GO:0060763 | |
| GeneOntologyBiologicalProcess | homeostasis of number of cells within a tissue | 1.32e-04 | 51 | 40 | 3 | GO:0048873 | |
| GeneOntologyBiologicalProcess | primitive hemopoiesis | 2.39e-04 | 12 | 40 | 2 | GO:0060215 | |
| GeneOntologyBiologicalProcess | mammary gland morphogenesis | 2.72e-04 | 65 | 40 | 3 | GO:0060443 | |
| GeneOntologyBiologicalProcess | positive regulation of regulated secretory pathway | 2.84e-04 | 66 | 40 | 3 | GO:1903307 | |
| Domain | ZnF_GATA | 1.98e-06 | 12 | 40 | 3 | SM00401 | |
| Domain | Znf_GATA | 4.07e-06 | 15 | 40 | 3 | IPR000679 | |
| Domain | GATA | 4.07e-06 | 15 | 40 | 3 | PF00320 | |
| Domain | GATA_ZN_FINGER_1 | 5.00e-06 | 16 | 40 | 3 | PS00344 | |
| Domain | GATA_ZN_FINGER_2 | 5.00e-06 | 16 | 40 | 3 | PS50114 | |
| Domain | TF_GATA-2/3 | 1.34e-05 | 3 | 40 | 2 | IPR016374 | |
| Domain | PAN_AP | 4.45e-05 | 5 | 40 | 2 | SM00473 | |
| Domain | PAN | 9.33e-05 | 7 | 40 | 2 | PS50948 | |
| Domain | Pan_app | 9.33e-05 | 7 | 40 | 2 | IPR003609 | |
| Domain | PAN_1 | 9.33e-05 | 7 | 40 | 2 | PF00024 | |
| Domain | - | 2.46e-04 | 57 | 40 | 3 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 2.59e-04 | 58 | 40 | 3 | IPR013088 | |
| Domain | Kringle | 5.96e-04 | 17 | 40 | 2 | IPR000001 | |
| Domain | Kringle | 5.96e-04 | 17 | 40 | 2 | PF00051 | |
| Domain | KRINGLE_1 | 5.96e-04 | 17 | 40 | 2 | PS00021 | |
| Domain | Kringle_CS | 5.96e-04 | 17 | 40 | 2 | IPR018056 | |
| Domain | KR | 5.96e-04 | 17 | 40 | 2 | SM00130 | |
| Domain | KRINGLE_2 | 5.96e-04 | 17 | 40 | 2 | PS50070 | |
| Domain | C2H2_Znf_fam | 1.20e-03 | 24 | 40 | 2 | IPR027775 | |
| Domain | Kringle-like | 2.13e-03 | 32 | 40 | 2 | IPR013806 | |
| Domain | CUB | 4.94e-03 | 49 | 40 | 2 | PF00431 | |
| Domain | CUB | 5.13e-03 | 50 | 40 | 2 | SM00042 | |
| Domain | Sushi | 5.54e-03 | 52 | 40 | 2 | PF00084 | |
| Domain | - | 5.54e-03 | 52 | 40 | 2 | 2.60.120.290 | |
| Domain | CUB | 5.75e-03 | 53 | 40 | 2 | PS01180 | |
| Domain | CCP | 5.97e-03 | 54 | 40 | 2 | SM00032 | |
| Domain | SUSHI | 6.40e-03 | 56 | 40 | 2 | PS50923 | |
| Domain | SCAN | 6.40e-03 | 56 | 40 | 2 | SM00431 | |
| Domain | Sushi_SCR_CCP_dom | 6.63e-03 | 57 | 40 | 2 | IPR000436 | |
| Domain | CUB_dom | 6.63e-03 | 57 | 40 | 2 | IPR000859 | |
| Domain | SCAN_BOX | 6.85e-03 | 58 | 40 | 2 | PS50804 | |
| Domain | SCAN | 6.85e-03 | 58 | 40 | 2 | PF02023 | |
| Domain | SCAN_dom | 6.85e-03 | 58 | 40 | 2 | IPR003309 | |
| Domain | Retrov_capsid_C | 7.08e-03 | 59 | 40 | 2 | IPR008916 | |
| Domain | TSP_1 | 8.04e-03 | 63 | 40 | 2 | PF00090 | |
| Domain | TSP1 | 8.54e-03 | 65 | 40 | 2 | SM00209 | |
| Domain | TSP1_rpt | 8.54e-03 | 65 | 40 | 2 | IPR000884 | |
| Domain | TSP1 | 8.54e-03 | 65 | 40 | 2 | PS50092 | |
| Domain | EGF_1 | 1.71e-02 | 255 | 40 | 3 | PS00022 | |
| Pathway | REACTOME_SIGNALING_BY_MST1 | 5.27e-05 | 6 | 27 | 2 | MM15492 | |
| Pathway | BIOCARTA_MSP_PATHWAY | 7.38e-05 | 7 | 27 | 2 | MM1580 | |
| Pathway | WP_MIR302367_PROMOTING_CARDIOMYOCYTE_PROLIFERATION | 9.82e-05 | 8 | 27 | 2 | MM15986 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 2.65e-04 | 66 | 27 | 3 | M101 | |
| Pubmed | 5.30e-08 | 7 | 41 | 3 | 18212046 | ||
| Pubmed | Gata6 restricts Isl1 to the posterior of nascent hindlimb buds through Isl1 cis-regulatory modules. | 8.48e-08 | 8 | 41 | 3 | 29197504 | |
| Pubmed | Gata6 is an important regulator of mouse pancreas development. | 8.42e-07 | 16 | 41 | 3 | 16887115 | |
| Pubmed | 1.02e-06 | 17 | 41 | 3 | 39147774 | ||
| Pubmed | Essential and instructive roles of GATA factors in eosinophil development. | 1.36e-06 | 2 | 41 | 2 | 12045236 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 10728827 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 16961763 | ||
| Pubmed | GATA-2 reinforces megakaryocyte development in the absence of GATA-1. | 1.36e-06 | 2 | 41 | 2 | 19620289 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 25340772 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 26766440 | ||
| Pubmed | Inhibiting endothelial cell Mst1 attenuates acute lung injury in mice. | 1.36e-06 | 2 | 41 | 2 | 39253972 | |
| Pubmed | Mst1 regulates post-infarction cardiac injury through the JNK-Drp1-mitochondrial fission pathway. | 1.36e-06 | 2 | 41 | 2 | 29760744 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 12432220 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 17347142 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 32017081 | ||
| Pubmed | Mst1 inhibition attenuates non-alcoholic fatty liver disease via reversing Parkin-related mitophagy. | 1.36e-06 | 2 | 41 | 2 | 30708325 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 24409221 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 19941826 | ||
| Pubmed | Melatonin alleviates postinfarction cardiac remodeling and dysfunction by inhibiting Mst1. | 1.36e-06 | 2 | 41 | 2 | 27696525 | |
| Pubmed | [Expression of GATA-1 and GATA-2 in the bone marrow of patients with Monge's disease]. | 1.36e-06 | 2 | 41 | 2 | 18078130 | |
| Pubmed | Functional overlap of GATA-1 and GATA-2 in primitive hematopoietic development. | 1.36e-06 | 2 | 41 | 2 | 14504093 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 18154321 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 8393443 | ||
| Pubmed | Chromatin occupancy analysis reveals genome-wide GATA factor switching during hematopoiesis. | 1.36e-06 | 2 | 41 | 2 | 22383799 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 12145700 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 12857954 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 25230694 | ||
| Pubmed | Hepatocyte-specific expression of the mouse hepatocyte growth factor-like protein. | 1.36e-06 | 2 | 41 | 2 | 8340069 | |
| Pubmed | Biological effects of targeted inactivation of hepatocyte growth factor-like protein in mice. | 1.36e-06 | 2 | 41 | 2 | 9486989 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 27609031 | ||
| Pubmed | GATA factor switching from GATA2 to GATA1 contributes to erythroid differentiation. | 1.36e-06 | 2 | 41 | 2 | 23911012 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 28179280 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 24980820 | ||
| Pubmed | Treatment with XMU-MP-1 erases hyperglycaemic memory in hearts of diabetic mice. | 1.36e-06 | 2 | 41 | 2 | 33887258 | |
| Pubmed | Progenitor stage-specific activity of a cis-acting double GATA motif for Gata1 gene expression. | 1.36e-06 | 2 | 41 | 2 | 25535330 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 25938541 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 31206688 | ||
| Pubmed | 2.31e-06 | 22 | 41 | 3 | 9811459 | ||
| Pubmed | 3.88e-06 | 26 | 41 | 3 | 24415953 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 12041667 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 27496379 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 12804176 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 12606483 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 22390417 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 12483298 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 15739164 | ||
| Pubmed | Antagonism of FOG-1 and GATA factors in fate choice for the mast cell lineage. | 4.06e-06 | 3 | 41 | 2 | 18299398 | |
| Pubmed | The Ron/STK receptor tyrosine kinase is essential for peri-implantation development in the mouse. | 4.06e-06 | 3 | 41 | 2 | 10225971 | |
| Pubmed | Mst1-mediated phosphorylation of Nur77 improves the endometrial receptivity in human and mice. | 4.06e-06 | 3 | 41 | 2 | 36623453 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 37184367 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 38430683 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 12538524 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 31409672 | ||
| Pubmed | Molecular hallmarks of endogenous chromatin complexes containing master regulators of hematopoiesis. | 4.06e-06 | 3 | 41 | 2 | 18779319 | |
| Pubmed | Mst1 controls lymphocyte trafficking and interstitial motility within lymph nodes. | 4.06e-06 | 3 | 41 | 2 | 19339990 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 15673499 | ||
| Pubmed | TRAF2 functions as an activator switch in the reactive oxygen species-induced stimulation of MST1. | 4.06e-06 | 3 | 41 | 2 | 26698664 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 38288506 | ||
| Pubmed | The proto-oncogene RON is involved in development of epithelial, bone and neuro-endocrine tissues. | 4.06e-06 | 3 | 41 | 2 | 8545120 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 25049204 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 12023274 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 35690555 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 1832957 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 18243117 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 25183307 | ||
| Pubmed | Dynamic regulation of Gata factor levels is more important than their identity. | 4.06e-06 | 3 | 41 | 2 | 17327407 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 35525373 | ||
| Pubmed | GATA-1, -2 and -3 genes expression in bone marrow microenviroment with chronic aplastic anemia. | 4.06e-06 | 3 | 41 | 2 | 17654061 | |
| Pubmed | MST1 coordinately regulates autophagy and apoptosis in diabetic cardiomyopathy in mice. | 4.06e-06 | 3 | 41 | 2 | 27510910 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 30063115 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 31976559 | ||
| Pubmed | Mst1-mediated phosphorylation of Bcl-xL is required for myocardial reperfusion injury. | 4.06e-06 | 3 | 41 | 2 | 27218122 | |
| Pubmed | Over-expressed MST1 impaired spatial memory via disturbing neural oscillation patterns in mice. | 4.06e-06 | 3 | 41 | 2 | 32468668 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 17395874 | ||
| Pubmed | Nicorandil alleviates myocardial injury and post-infarction cardiac remodeling by inhibiting Mst1. | 4.06e-06 | 3 | 41 | 2 | 29127009 | |
| Pubmed | Mst1 Kinase Regulates the Actin-Bundling Protein L-Plastin To Promote T Cell Migration. | 4.06e-06 | 3 | 41 | 2 | 27465533 | |
| Pubmed | Genetic deletion of Mst1 alters T cell function and protects against autoimmunity. | 4.06e-06 | 3 | 41 | 2 | 24852423 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 30771091 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 19212333 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 12077323 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 15215894 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 19491391 | ||
| Pubmed | MST1 mediates the N-methyl-D-aspartate-induced excitotoxicity in mouse cortical neurons. | 4.06e-06 | 3 | 41 | 2 | 34967918 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 38898027 | ||
| Pubmed | Regulation of GATA factor expression is distinct between erythroid and mast cell lineages. | 4.06e-06 | 3 | 41 | 2 | 22988301 | |
| Pubmed | WASP and Mst1 coregulate B-cell development and B-cell receptor signaling. | 4.06e-06 | 3 | 41 | 2 | 32045478 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 27940445 | ||
| Pubmed | Mst1 regulates hepatic lipid metabolism by inhibiting Sirt1 ubiquitination in mice. | 8.12e-06 | 4 | 41 | 2 | 26903296 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 23527007 | ||
| Pubmed | Transcription factor GATA1 is dispensable for mast cell differentiation in adult mice. | 8.12e-06 | 4 | 41 | 2 | 24615013 | |
| Pubmed | A cell-intrinsic role for Mst1 in regulating thymocyte egress. | 8.12e-06 | 4 | 41 | 2 | 19692642 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 21078906 | ||
| Pubmed | MST1 controls murine neutrophil homeostasis via the G-CSFR/STAT3 axis. | 8.12e-06 | 4 | 41 | 2 | 36618429 | |
| Pubmed | Melatonin protects against diabetic cardiomyopathy through Mst1/Sirt3 signaling. | 8.12e-06 | 4 | 41 | 2 | 28480597 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 16892067 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 25659841 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 35715527 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 26538561 | ||
| Pubmed | SENP1-mediated GATA1 deSUMOylation is critical for definitive erythropoiesis. | 8.12e-06 | 4 | 41 | 2 | 20457756 | |
| Pubmed | MST1 functions as a key modulator of neurodegeneration in a mouse model of ALS. | 8.12e-06 | 4 | 41 | 2 | 23818595 | |
| Cytoband | 2q33.1 | 9.65e-04 | 51 | 41 | 2 | 2q33.1 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.19e-06 | 15 | 26 | 3 | 82 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.02e-03 | 57 | 26 | 2 | 1179 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.84e-02 | 718 | 26 | 4 | 28 | |
| ToppCell | 21-Trachea-RBC|Trachea / Age, Tissue, Lineage and Cell class | 2.58e-08 | 197 | 41 | 6 | 9f8eb6305ade0654bbcd8f19963be0b64af083de | |
| ToppCell | 21-Trachea-RBC-RBC|Trachea / Age, Tissue, Lineage and Cell class | 2.58e-08 | 197 | 41 | 6 | 4710b55806a618076a954190f519e49c55d300d3 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Polychromatic_Erythroblast|World / Lineage, cell class and subclass | 9.35e-07 | 194 | 41 | 5 | 008bb0072f414a48d052429101bdc990ee4f80c2 | |
| ToppCell | 15-Trachea-RBC-RBC|Trachea / Age, Tissue, Lineage and Cell class | 9.84e-07 | 196 | 41 | 5 | 511bfc06c34d5add2ae561cca463d1e4e2d43e20 | |
| ToppCell | 15-Trachea-RBC|Trachea / Age, Tissue, Lineage and Cell class | 9.84e-07 | 196 | 41 | 5 | bf2670e5ae996a19987bc70aa5a37d133db789eb | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.06e-05 | 149 | 41 | 4 | 6e9ca280a599d96f8956ef26f2a46b9484de5488 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.15e-05 | 152 | 41 | 4 | 32634195048858ae84605c61e43c542d90f7cab5 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.15e-05 | 152 | 41 | 4 | 0eb185b2404f015efff1bd140e0c502d714720fb | |
| ToppCell | 11.5-Airway-RBC-RBC|Airway / Age, Tissue, Lineage and Cell class | 1.59e-05 | 165 | 41 | 4 | 8618b2c5659aa70c7c9d6e51a227ac612b4ad17b | |
| ToppCell | 11.5-Airway-RBC|Airway / Age, Tissue, Lineage and Cell class | 1.59e-05 | 165 | 41 | 4 | 46042340a373adaf1c439b2301e02fbae3e31a4f | |
| ToppCell | 343B-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-05 | 166 | 41 | 4 | 4e47e7f3019fb2dcbc35b4e9b47ee265a97cec5c | |
| ToppCell | 343B-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-05 | 166 | 41 | 4 | f6e2ec767c022982ef416fadb998a7b6b958f76a | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-05 | 167 | 41 | 4 | 8b223333c0c7a85b5a1af6f2f5b12ee0d94357f6 | |
| ToppCell | facs-Marrow-B-cells-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 168 | 41 | 4 | d4053b2fffb19e0376b8ceb92e87ec4447d96a3e | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.71e-05 | 168 | 41 | 4 | 45ccc0cb42d21f4853190e8e9ed9a54aefefe738 | |
| ToppCell | facs-Marrow-B-cells-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 168 | 41 | 4 | 08fe8fa43c343c03f9a2f0b982192fde04a7c027 | |
| ToppCell | 368C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.91e-05 | 173 | 41 | 4 | 8cffb4a37d30b6626188309b868ac4a62e91262f | |
| ToppCell | 368C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.91e-05 | 173 | 41 | 4 | fb87ea74bf70aa83b458edf728c81857c8b8eb96 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Cycling_definitive_erythroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.05e-05 | 176 | 41 | 4 | 98814f0a67411b2f7b25dc489b2aadb77f45a853 | |
| ToppCell | facs-Aorta|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 176 | 41 | 4 | 0b3491451be02c18a16cdb875645be47eb867a7f | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Mast_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.09e-05 | 177 | 41 | 4 | 0176ffa5e66fa684d0a8264af0db8f77fc391afd | |
| ToppCell | LAM-Myeloid-Mast|Myeloid / Condition, Lineage and Cell class | 2.14e-05 | 178 | 41 | 4 | 19cb1a46ba2f5c19180b6b0586acfaf075afff1c | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-monocytoid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.24e-05 | 180 | 41 | 4 | ba4c1fb55e8f1095bea6968417fefcf5f700926b | |
| ToppCell | severe-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.24e-05 | 180 | 41 | 4 | ac03812b1409435c55d323a7516deeac82bd3509 | |
| ToppCell | critical-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.28e-05 | 181 | 41 | 4 | f0d81ae74d3f32979624a94b2ef93774831a7970 | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.44e-05 | 184 | 41 | 4 | 5535b85b3ad3d0c0392d5884fdc2939c7e1b1c3e | |
| ToppCell | IPF-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 2.44e-05 | 184 | 41 | 4 | 7326a16d7d3ae41b8c9d2beaec7f977b374f3469 | |
| ToppCell | IPF-Myeloid-Mast|IPF / Disease state, Lineage and Cell class | 2.44e-05 | 184 | 41 | 4 | c3baf21f10b45cf91ac99997a59f353bcf3de8b7 | |
| ToppCell | COVID-19_Convalescent-Myeloid-cDC|COVID-19_Convalescent / Disease group, lineage and cell class | 2.44e-05 | 184 | 41 | 4 | ad6e910eaebe841a68a5f2f329d43dafc5db158a | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-luminal_bladder_epithelial_cell_(umbrella_cell)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 184 | 41 | 4 | 382b1e90b3f437af596750669c0465a169d97095 | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC-cDC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.44e-05 | 184 | 41 | 4 | 9d678b24532b7763f2e73f7ccb496259977c5204 | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC-cDC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.44e-05 | 184 | 41 | 4 | 383374ad17bd322b8d703a22e475d34ca7b2e6b6 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.44e-05 | 184 | 41 | 4 | bc394eaa441fcaffcc4ace062741bca1da229324 | |
| ToppCell | IPF-Myeloid-Mast|World / Disease state, Lineage and Cell class | 2.44e-05 | 184 | 41 | 4 | 7aefa182acad5a53c730945fec85329d7168606a | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Mast_cells|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.49e-05 | 185 | 41 | 4 | a6e5328801c233a44153420e2cdae644b253f540 | |
| ToppCell | 367C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.59e-05 | 187 | 41 | 4 | 7d416693cb719df4197a11acc6b4e19171352515 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_urothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 187 | 41 | 4 | aa336fb568a24e12c0454265ddd71ed10a6614cf | |
| ToppCell | 367C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.59e-05 | 187 | 41 | 4 | b1341d272d9fc07c6f7590d6d398d7a5cf42240b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 188 | 41 | 4 | a244fcd092d5bd544e503366b1439b0fbc1ee00e | |
| ToppCell | Mast_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.65e-05 | 188 | 41 | 4 | 229d24b87e945c4d543d11ac70761e45175ba0e5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 188 | 41 | 4 | c8530c9ff98666c64a94683261af4288cb790a7e | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-05 | 189 | 41 | 4 | 1893765b1e3b306f1e133101c28403070a70c3c8 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid_mast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-05 | 189 | 41 | 4 | 96566f84c796d5b2e31f64090555f2b258f0c9f2 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid_mast-Myeloid_Mast/Baso|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-05 | 189 | 41 | 4 | 19b639bc6b35fe1d1079f60c8138aa946a95f3bf | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-05 | 189 | 41 | 4 | b59cc66f7bb9b72895b775fbcf1ec1dc08610969 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 190 | 41 | 4 | 9b825b2586c7b173ff27fcf2abc5860faf50984a | |
| ToppCell | COPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 2.76e-05 | 190 | 41 | 4 | 379dbac19110b76079a7a53209569e060a852acb | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 190 | 41 | 4 | d146af1926474328a7c822bc140c4dda66e1bbfb | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.88e-05 | 192 | 41 | 4 | 6ace9a34ed264583042156ed61c2cb3504a331d2 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.C1ql3_(VTA_(dorsal_VTA))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.95e-05 | 65 | 41 | 3 | 4382d56d5f71c7acfe35f84db7257aba2a7dd36a | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.C1ql3_(VTA_(dorsal_VTA))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.95e-05 | 65 | 41 | 3 | 05b712f83d88e864747cd0229a39aca17321e0f8 | |
| ToppCell | distal-Hematologic-Basophil/Mast_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.06e-05 | 195 | 41 | 4 | 4f83449fce3717518e2acbba1a4b3bea765c0bdb | |
| ToppCell | distal-3-Hematologic-Basophil/Mast_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.06e-05 | 195 | 41 | 4 | 009986b5b32a7df3bdbe6cc1adf48023060f454f | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.12e-05 | 196 | 41 | 4 | 2aeb792e7685e33e3543a6974be790980a41ed8c | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.18e-05 | 197 | 41 | 4 | b71da7f2fd8d526fb6e5d57e60fc08acdd8dbefb | |
| ToppCell | erythropoietic-Polychromatic_Erythroblast|World / Lineage and Cell class | 3.18e-05 | 197 | 41 | 4 | 604fcbf47f073c2af344e1b16b615a78ef838dc9 | |
| ToppCell | Biopsy_Other_PF-Immune-Mast_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.24e-05 | 198 | 41 | 4 | 9f015553598d4c6774b2f9759e8c0f0f93e51c67 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-erythroid-early_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.24e-05 | 198 | 41 | 4 | 8d900a17667a41bdfa683a34275fe4c059f6a8ef | |
| ToppCell | mLN-Dendritic_cell-cDC2|mLN / Region, Cell class and subclass | 3.31e-05 | 199 | 41 | 4 | cb17bccb47d04f7793709f9a4376fcc8ce95430c | |
| ToppCell | mLN-(5)_Dendritic_cell-(50)_cDC2|mLN / shred on region, Cell_type, and subtype | 3.31e-05 | 199 | 41 | 4 | 8d1b18596a0965427abefe0be744c74e4c11d5d3 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | 9156f8fd61a833891d2f7b7fadd693b81b1e2d5a | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-Mast_cells|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.37e-05 | 200 | 41 | 4 | 56e2284df161e8ca32ce3e358369611345f4414e | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Mast_cell-Mast_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.37e-05 | 200 | 41 | 4 | 4090f2ab8529a530043f3917472f2d9ca7c9b1df | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 3.37e-05 | 200 | 41 | 4 | 988390516db3445d2d4de283be79e651c5798338 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | 566fe2e78e6f35399ec6aad5964f6d4d8ade82c6 | |
| ToppCell | Biopsy_Control_(H.)-Immune-Mast_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.37e-05 | 200 | 41 | 4 | 64bf125e0e5652a5a638a6bb32eb109cb0d5e232 | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Mast_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.37e-05 | 200 | 41 | 4 | cc78aa3e29f6c0a44c373dde7785c0e61978cf2d | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Mast_cell|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | 21de2cf284c8d2aa464f3d403f0e292e1f654e0a | |
| ToppCell | COVID-19-COVID-19_Convalescent-Myeloid-cDC|COVID-19_Convalescent / Disease, condition lineage and cell class | 3.37e-05 | 200 | 41 | 4 | ac9d7927863348a752444d2e80269a5eead943b7 | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Mast_cell-Mast_cells|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.37e-05 | 200 | 41 | 4 | c3150b4bb621534b0094306b29534dbbe4ef7357 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Mast_cell-Mast_cell|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | a338b2b94901e4614ef78e82f580b67891f7c849 | |
| ToppCell | droplet-Liver-Npc-21m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-05 | 75 | 41 | 3 | 7f3be37cc378ee115fcb4b0eb9653fc77447aa0a | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Pnoc_(Fast-spiking_interneuron,_Pvalb+/Pnoc+)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.42e-04 | 110 | 41 | 3 | 41306a2d4a5a39569437eb123e47f98ef8afab24 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Pnoc_(Fast-spiking_interneuron,_Pvalb+/Pnoc+)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.42e-04 | 110 | 41 | 3 | 1fe08060248b25329f73b80d74435c108bee1359 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Pnoc_(Fast-spiking_interneuron,_Pvalb+/Pnoc+)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.42e-04 | 110 | 41 | 3 | 5496c92932195386025254b9129d69b12c8e3340 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.53e-04 | 113 | 41 | 3 | 34ae3dec5ec7585d155ea61de6adc42aa4f45226 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.53e-04 | 113 | 41 | 3 | 79ba2eb8f85e5da4c19c838df881c18ffdc450fb | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.53e-04 | 113 | 41 | 3 | 91d55fe6fb1c1472867d74461f5b9e4f17db01cd | |
| ToppCell | P07-Hematopoietic-Erythroid|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.70e-04 | 117 | 41 | 3 | 1820396bd590020a83fac3416d559e32f41eab61 | |
| ToppCell | P07-Hematopoietic-Erythroid-enucleate_erythrocyte|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.70e-04 | 117 | 41 | 3 | 43c7257788fe3d53d663365d1754aee6ad88bbc5 | |
| ToppCell | mild_COVID-19-RBC|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.83e-04 | 120 | 41 | 3 | cccea760901558ec18d5cbb71c7971c5a51da571 | |
| ToppCell | Bronchial-10x5prime-Hematologic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.12e-04 | 126 | 41 | 3 | b6482ef18e6d9e12ba4810ce7845f9f991cb95bc | |
| ToppCell | Bronchial-10x5prime-Hematologic-Erythrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.12e-04 | 126 | 41 | 3 | 65c7c0e4cfb5ac58d80b4034d42e9f662116e0d3 | |
| ToppCell | Bronchial-10x5prime-Hematologic-Erythrocyte-Erythrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.12e-04 | 126 | 41 | 3 | 12f3d0f60db462f2a9799b3a06005bc871670760 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-04 | 135 | 41 | 3 | 7b456fa9a5f5ce58976a8f1fad18c0f96a096930 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-04 | 137 | 41 | 3 | 48c21e6938a46e3cd74ac10b8ace0a4751741af7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.07e-04 | 143 | 41 | 3 | d0ed8c25da1327085e042c2e03cb7503e2c52ce0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.07e-04 | 143 | 41 | 3 | 8900b92a24289204b9ec7baccc11594fec7694f1 | |
| ToppCell | NS-critical-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.13e-04 | 144 | 41 | 3 | 0fde5cd82df9b90aefde19275cff6c2ec3c9d5cb | |
| ToppCell | MS-CD8-CD8_2|MS / Condition, Cell_class and T cell subcluster | 3.53e-04 | 150 | 41 | 3 | 01c20d787ce269db0d153e63a600a8d9ead61856 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.60e-04 | 151 | 41 | 3 | cba0939a6dd3519f6890695f5b237266ca1a7941 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.60e-04 | 151 | 41 | 3 | bbf735c6433c3fc2feedb24ed6f48c51d545fb60 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.60e-04 | 151 | 41 | 3 | a937e3e5a63bfeb37d2cabb3177760ec583dbf11 | |
| ToppCell | 368C-Myeloid-Mast_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.67e-04 | 152 | 41 | 3 | faf30245a1690aaa27c7be0832797c340e4af4d7 | |
| ToppCell | 368C-Myeloid-Mast_cell-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.67e-04 | 152 | 41 | 3 | 519c9ed05fdaf420e42147ffae1dc05a7f86fdd4 | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-04 | 153 | 41 | 3 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-04 | 155 | 41 | 3 | 9b26ade19488511c72b64335011d2dcd81e8f167 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-04 | 155 | 41 | 3 | cd2f3ad4f131588325a667b6724e530d821fbe30 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-04 | 155 | 41 | 3 | 4246709e27703b94529369abbed5763e4002e79d | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.96e-04 | 156 | 41 | 3 | 841d653d74c4de41d2f9a114f6ccb92d6a1ebc24 | |
| Disease | myelofibrosis (is_marker_for) | 2.68e-05 | 6 | 40 | 2 | DOID:4971 (is_marker_for) | |
| Disease | acute myeloid leukemia (is_marker_for) | 4.07e-05 | 49 | 40 | 3 | DOID:9119 (is_marker_for) | |
| Disease | circadian rhythm | 7.02e-05 | 163 | 40 | 4 | EFO_0004354 | |
| Disease | depressive disorder (is_implicated_in) | 2.41e-04 | 17 | 40 | 2 | DOID:1596 (is_implicated_in) | |
| Disease | Acute myeloid leukemia | 2.41e-04 | 17 | 40 | 2 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 2.41e-04 | 17 | 40 | 2 | 601626 | |
| Disease | myelodysplastic syndrome (is_marker_for) | 3.35e-04 | 20 | 40 | 2 | DOID:0050908 (is_marker_for) | |
| Disease | inflammatory bowel disease (implicated_via_orthology) | 5.27e-04 | 25 | 40 | 2 | DOID:0050589 (implicated_via_orthology) | |
| Disease | Hematopoetic Myelodysplasia | 7.11e-04 | 29 | 40 | 2 | C2713368 | |
| Disease | clear cell renal cell carcinoma (is_marker_for) | 9.21e-04 | 33 | 40 | 2 | DOID:4467 (is_marker_for) | |
| Disease | urate measurement | 1.22e-03 | 895 | 40 | 6 | EFO_0004531 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TWANEVEDRRPQCTP | 116 | P0DMU3 | |
| RESCPQRAWGAQGQD | 456 | A0A096LP49 | |
| WEPFTEVQGSQRCEL | 406 | Q6UY14 | |
| QDGNVVWSSTVPRCE | 741 | Q96PZ7 | |
| ISDICENGRPRSNSW | 821 | Q9P0K1 | |
| RTARDQCGSQPWDNN | 51 | P24864 | |
| SNWRCPTRVQEDQQR | 156 | Q4W4Y0 | |
| CSLSGEDLNRQWQSP | 971 | Q9UPW5 | |
| DENCRSWNEGTLSGQ | 191 | Q52LD8 | |
| NSTPSQEERRATQWG | 1721 | Q9HCM3 | |
| ESPCGRWQKRREQVN | 31 | Q9NSY0 | |
| QDEEESPSQRCSRNW | 241 | Q9BZ81 | |
| VNEITCENTEWPGQR | 46 | Q8TD10 | |
| TESGRECQRWDLQHP | 176 | Q2TV78 | |
| NLRDLNRCTPEGWSE | 126 | Q8N4P3 | |
| NRCTPEGWSEHRVQE | 131 | Q8N4P3 | |
| TNTTQDEQRRWPGCD | 56 | O75387 | |
| CASRRSQPVDQDWNS | 1561 | Q9H6A9 | |
| NDSQSEDCETRQWLP | 6 | P43116 | |
| RTRTISNCPNPEWNE | 106 | Q3MJ16 | |
| PCRNWSSASELNETQ | 11 | O43614 | |
| SPNCTEEITEGVWNR | 471 | P36888 | |
| TTLWRRNASGDPVCN | 266 | P15976 | |
| TTTLWRRNANGDPVC | 356 | P23769 | |
| TTLWRRNSEGEPVCN | 251 | Q9BWX5 | |
| AQSCQRRPTSWLDEQ | 2251 | O43497 | |
| CQRRTSNVGESNLWP | 626 | Q6ZN84 | |
| RQGRPQSWQDVRCQS | 161 | Q13751 | |
| TESGRECQRWDLQHP | 206 | P26927 | |
| QSSRERECGQTDQWG | 56 | Q96B33 | |
| SRLVRPQNWGENSCE | 216 | Q8NBS3 | |
| RNDSCSDLPEIQNGW | 741 | Q9BYH1 | |
| QTSESGPSQRDWQNE | 331 | Q6ZUK4 | |
| VVPGCVTQSQADWDR | 256 | P49683 | |
| VNADPEVQRCSSWRE | 366 | Q7Z6J9 | |
| SGSWAPECREEQSQS | 4191 | A2VEC9 | |
| TERSDGLQWSAEQPC | 171 | Q9NUQ6 | |
| QQSWEQSRVGQLCRE | 1421 | Q7RTU9 | |
| TQAWVCSRQPQSGEE | 76 | Q8N0Y2 | |
| TWVQSQGPRSCREAA | 96 | Q8NBB4 | |
| TSCAVDQENQDPRRW | 36 | Q12815 | |
| RNGNEANRWCAEPSS | 151 | Q9Y2K1 | |
| QQWGEASSPISRNRD | 31 | Q16600 | |
| SPQSSQASRQDEWDR | 716 | Q01538 |